Outset Medical Future Growth

Future criteria checks 1/6

Outset Medical is forecast to grow earnings and revenue by 34.2% and 11% per annum respectively while EPS is expected to grow by 35.6% per annum.

Key information

34.2%

Earnings growth rate

35.6%

EPS growth rate

Medical Equipment earnings growth17.1%
Revenue growth rate11.0%
Future return on equityn/a
Analyst coverage

Good

Last updated13 Nov 2024

Recent future growth updates

Outset Medical, Inc. (NASDAQ:OM) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Aug 11
Outset Medical, Inc. (NASDAQ:OM) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Recent updates

Further Upside For Outset Medical, Inc. (NASDAQ:OM) Shares Could Introduce Price Risks After 32% Bounce

Nov 08
Further Upside For Outset Medical, Inc. (NASDAQ:OM) Shares Could Introduce Price Risks After 32% Bounce

Outset Medical, Inc. (NASDAQ:OM) Might Not Be As Mispriced As It Looks After Plunging 27%

Sep 24
Outset Medical, Inc. (NASDAQ:OM) Might Not Be As Mispriced As It Looks After Plunging 27%

Outset Medical, Inc. (NASDAQ:OM) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Aug 11
Outset Medical, Inc. (NASDAQ:OM) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Outset Medical, Inc. (NASDAQ:OM) Stock Rockets 25% But Many Are Still Ignoring The Company

Jul 17
Outset Medical, Inc. (NASDAQ:OM) Stock Rockets 25% But Many Are Still Ignoring The Company

Outset Medical: Expecting Accelerated Growth And Reduced Cash Burn Going Forward

May 28

Outset Medical, Inc.'s (NASDAQ:OM) CEO Compensation Is Looking A Bit Stretched At The Moment

May 23
Outset Medical, Inc.'s (NASDAQ:OM) CEO Compensation Is Looking A Bit Stretched At The Moment

Investors Still Aren't Entirely Convinced By Outset Medical, Inc.'s (NASDAQ:OM) Revenues Despite 30% Price Jump

May 10
Investors Still Aren't Entirely Convinced By Outset Medical, Inc.'s (NASDAQ:OM) Revenues Despite 30% Price Jump

Not Many Are Piling Into Outset Medical, Inc. (NASDAQ:OM) Stock Yet As It Plummets 29%

Feb 14
Not Many Are Piling Into Outset Medical, Inc. (NASDAQ:OM) Stock Yet As It Plummets 29%

Outset Medical, Inc.'s (NASDAQ:OM) Earnings Haven't Escaped The Attention Of Investors

Jun 09
Outset Medical, Inc.'s (NASDAQ:OM) Earnings Haven't Escaped The Attention Of Investors

Outset Medical: Tablo Ship Hold A Key Overhang To Unlock Risk Capital

Sep 20

Outset Medical awarded VA contract for hemodialysis

Aug 15

Outset Medical jumps 24% after 2Q results as FDA clears hemodialysis system

Aug 01

Outset Medical: Margins Leave No Tangible Value Flow, Pricing 18% Downside

Jul 06

Earnings and Revenue Growth Forecasts

NasdaqGS:OM - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026144-76N/AN/A5
12/31/2025124-90N/AN/A7
12/31/2024112-121N/AN/A7
9/30/2024115-141-126-124N/A
6/30/2024116-159-140-138N/A
3/31/2024125-169-136-133N/A
12/31/2023130-173-135-131N/A
9/30/2023132-176-146-141N/A
6/30/2023129-170-148-142N/A
3/31/2023118-170-160-152N/A
12/31/2022115-163-154-146N/A
9/30/2022112-163-151-144N/A
6/30/2022110-152-143-138N/A
3/31/2022110-139-134-130N/A
12/31/2021103-132-133-130N/A
9/30/202192-123-128-123N/A
6/30/202179-135-130-124N/A
3/31/202166-131-120-113N/A
12/31/202050-79-108-99N/A
9/30/202040-67-95-88N/A
6/30/202029-41-82-76N/A
3/31/202020-40-82-77N/A
12/31/201915-85-74-70N/A
12/31/20182-73-48-46N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: OM is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: OM is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: OM is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: OM's revenue (11% per year) is forecast to grow faster than the US market (8.9% per year).

High Growth Revenue: OM's revenue (11% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if OM's Return on Equity is forecast to be high in 3 years time


Discover growth companies